Skip to content
MarketScale
‹ Back to IndustriesSoftware & Technology

Applying Oncology Expertise At Scale, Part 3

April Boyd, Sr. Clinical Content Developer at Carevive, is a nurse with many years of oncology experience. Boyd understands what it takes to achieve better patient outcomes. She worked as an outpatient oncology nurse and research nurse for gastrointestinal cancers at MD Anderson in Houston. She spoke with Tyler Kern about her experiences and what…

This story was produced through MarketScale. See how Software & Technology teams put it to work with Executive Thought Leadership.

By Healthcare · Cancer Patient OutcomesClinical ExperienceHealthcareOncology Insights
Share

Key takeaways

01

Clinical Content Developer at Carevive, is a nurse with many years of oncology experience.

02

Boyd understands what it takes to achieve better patient outcomes.

03

She worked as an outpatient oncology nurse and research nurse for gastrointestinal cancers at MD Anderson in Houston.

April Boyd, Sr. Clinical Content Developer at Carevive, is a nurse with many years of oncology experience. Boyd understands what it takes to achieve better patient outcomes. She worked as an outpatient oncology nurse and research nurse for gastrointestinal cancers at MD Anderson in Houston. She spoke with Tyler Kern about her experiences and what led her to Carevive.

Boyd joined Carevive in 2019 in content development to help create the company’s remote symptom monitoring and management practice. She didn’t intend to focus on oncology, but the fantastic people she encountered in the field and oncology practitioners’ approach toward patient care and treatment resonated with her.

Boyd’s role at Carevive may differ from her nursing days, but it is no less rewarding. “It’s super interesting to me,” Boyd said. “It always gets me excited to take the things we have that we’re doing well and figure out how to do them even better.” Boyd acknowledged gaps in care where people are not getting the holistic care or equity of care they need.

This motivates and informs her work at Carevive, which helps the company’s “features resonate and be effective and valuable” for clinicians and patients alike. “It just gets me excited to be able to dig in and figure out which levers we can pull to get that right,” Boyd said.

Boyd’s previous experience working in oncology is paying off in her role with Carevive. “I understand how it is to be working with those patients, and talking to patients, and coming up against those care gaps,” Boyd said. “So, the conversation is very easy between me and the customers, or the patients who might be advising us, because I have that clinical experience.”

About the author

H
Healthcare

Software & Technology: are you visible to AI?

Before they reach out, Software & Technology buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Software & Technology Insights

Buying AI tools isn't enough: two reports show strategy, not spend, drives enterprise returns

Buying AI tools isn't enough: two reports show strategy, not spend, drives enterprise returns

Reports from BCG and Ramp/Revelio Labs indicate that having a clear strategy for AI use is more critical for driving enterprise returns than merely investing in AI tools. According to the data, 66% of regular AI users receive minimal guidance. Strategic clarity proves to have a more substantial impact on measurable outcomes compared to just having access to AI tools.

  • 01Strategic clarity is crucial for maximizing AI returns.
  • 02Merely investing in AI tools is insufficient without guidance.
  • 0366% of regular AI users report lack of guidance.

Jul 13, 2026

Buying AI tools isn't enough: two reports show strategy, not spend, drives enterprise returns

Buying AI tools isn't enough: two reports show strategy, not spend, drives enterprise returns

Two reports suggest that simply investing in AI tools does not guarantee enterprise returns. Strategic planning and guidance for workers on utilizing AI effectively are essential. The reports highlight that while some companies have expanded their workforce, many employees lack guidance on new efficiencies from AI.

  • 01Investing in AI tools alone is not enough for enterprise success.
  • 02Strategic planning enhances returns on AI investments.
  • 03Many workers are left without guidance on using AI efficiencies.

Jul 13, 2026

B2B ecommerce is posting real numbers — and operators are taking notice

B2B ecommerce is posting real numbers — and operators are taking notice

B2B ecommerce is showing significant growth, with MSC Industrial surpassing $1 billion in sales in Q3. This trend highlights increasing adoption among procurement and operations teams. The data suggests a shift in how businesses are engaging with ecommerce platforms.

  • 01MSC Industrial's Q3 sales exceeded $1 billion.
  • 02B2B ecommerce adoption is accelerating.
  • 03Procurement and operations teams are increasingly engaging with ecommerce platforms.

Jul 13, 2026

Explore More Software & Technology Insights

Read more expert perspectives from across Software & Technology.

Browse Software & Technology Hub

About the Expert

H
Healthcare

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Software & Technology and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512